![]() |
|
|
Vol. 292, Issue 1, 67-75, January 2000
-Adrenergic Stimulation on the Acutely Obstructed
Ureter in Dogs
Division of Discovery Research, Kissei Pharmaceutical Co., Ltd.,
Nagano (M.M., Y.T., K.H., M.A., Y.A.); and Department of Urology, Kinki
University School of Medicine, Osaka, Japan (Y.-C.P., N.O., T.S., T.K.)
The objective of the present study was to evaluate the effects of
a selective
3-adrenoceptor agonist,
(R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316243), on the acutely obstructed ureter in anesthetized dogs.
After a complete ureteral obstruction produced by the inflation of a
balloon catheter placed within the left lower ureter, the intraluminal
ureteral pressure gradually rose to reach a plateau of ~52.5 mm Hg.
Intravenous administration of isoproterenol (a nonselective
-adrenoceptor agonist; 10 µg/kg) and CL 316243 (1 µg/kg)
significantly decreased this elevated ureteral pressure (by 74.1 and
77.2%, respectively), with the reduction more sustained with CL 316243 than with isoproterenol. In addition, under both isoproterenol and CL
316243, urine flow (which had been interrupted by the balloon) was
resumed, resulting in further sustained decreases in ureteral pressure.
The mean blood pressure decreased and heart rate increased after the
administration of both drugs, but these changes were greater in the
isoproterenol group than in the CL 316243 group. In contrast, i.v.
administration of butylscopolamine (an anticholinergic agent; 1000 µg/kg) had no evident effects on ureteral pressure or on urine flow.
The increase in left kidney weight seen after ureteral obstruction was
suppressed by CL 316243. We conclude that the selective
3-adrenoceptor agonist tested appears to be more useful
than isoproterenol for reducing ureteral pressure above the obstructed
site and for promoting ureteral relaxation and increasing urine flow
around the point of obstruction in dogs.